# Petrelintide combination study record posted

> ClinicalTrials.gov lists a Petrelintide study that is not yet recruiting sponsored by Hoffmann-La Roche.

- Evidence object: `story:petrelintide-combination-study-posted:v1`
- Evidence domain: Clinical trials
- Date in source: 2026-07-07
- Source checked: 2026-07-22
- Published by PeptideScanner: 2026-07-22
- Story landing page: https://peptidescanner.com/stories/petrelintide-combination-study-posted/
- JSON record: https://peptidescanner.com/evidence/v1/objects/petrelintide-combination-study-posted-v1.json
- Content SHA-256: `94b4f707af2b747517f454d9544ec823dafc8d6bb5a831c3b014799a9d638aea`

## Claims and source pins

### Headline

Petrelintide combination study record posted ([`ctg-nct07589686-v3`](#source-ctg-nct07589686-v3))

### Summary

ClinicalTrials.gov lists a Petrelintide study that is not yet recruiting sponsored by Hoffmann-La Roche. ([`ctg-nct07589686-v3`](#source-ctg-nct07589686-v3))

### Paragraph 1

ClinicalTrials.gov lists the NCT07589686 record under Hoffmann-La Roche. Its overall recruitment status was shown as not yet recruiting when PeptideScanner reviewed the record. ([`ctg-nct07589686-v3`](#source-ctg-nct07589686-v3))

### Paragraph 2

The registry shows 2026-07-07 as its latest posted update date. This update reports the registry record and does not establish safety, effectiveness, or a trial outcome. ([`ctg-nct07589686-v3`](#source-ctg-nct07589686-v3))

## Sources

<a id="source-ctg-nct07589686-v3"></a>
- **Petrelintide With Enicepatide in Adults With Obesity or Overweight · record history version 3 · last update posted 2026-07-07** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT07589686?a=3&tab=history) (`ctg-nct07589686-v3`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "Petrelintide combination study record posted." Version 1, published 2026-07-22. https://peptidescanner.com/evidence/v1/objects/petrelintide-combination-study-posted-v1.json SHA-256: 94b4f707af2b747517f454d9544ec823dafc8d6bb5a831c3b014799a9d638aea.